Helius Medical Technologies announced the enrollment of the first three subjects in the Multiple Sclerosis feasibility study at the Montreal Neurological Institute and Hospital and Concordia’s PERFORM Center.
from Content Keyword RSS http://ift.tt/1Dvv8gl
via IFTTT
from Content Keyword RSS http://ift.tt/1Dvv8gl
via IFTTT
No comments:
Post a Comment